Liver study notes 05
Tesamorelin liver fat fell during HIV treatment
Scans found less fat, but they couldn't show that liver scars healed.
Tesamorelin lowered liver fat during treatment
A dull fullness may sit under your right ribs. Yet fatty liver often causes no clear feeling. Fatty liver means fat has built up inside liver cells.
Researchers tested tesamorelin in volunteers being treated for HIV. They scanned each liver before and after daily shots. The scans found less liver fat during treatment.
The studies haven't shown that liver scars healed or slowed. Tesamorelin isn't approved for fatty liver disease. That use remains outside the approved label. Your doctor may use other tests to judge liver health.
Tesamorelin liver scans measured a clear drop
Doctors scanned 50 adults before and after the shots. Tesamorelin lowered more liver fat than placebo, a shot with no medicine [6]. The scan measured fat inside the liver.
Another trial followed 61 volunteers with HIV. Liver fat fell 37% compared with placebo [7]. In that trial, 35% reached a reading below 5%, a level the study treated as normal. Only 4% of the placebo group reached that level.
A 2024 study found a drop over 12 months [9]. Researchers then combined five trials in a 2026 review [8], which agreed that liver fat fell. Fat stayed lower while treatment continued. You can see each scan result in the fatty liver research findings.
Less belly fat may mean less fat reaches the liver
Fatty liver can worsen faster during HIV care [13][14]. Tesamorelin doesn't have approval for that liver disease. Medical reviews say the early results deserve more study.
Deep belly fat can send more fat toward the liver [6][8]. That flow can add fat inside liver cells. Belly fat and liver fat fell together in the trials. Doctors still don't know whether tesamorelin also acts on liver cells.
HIV care can involve both belly fat and liver fat
A 2025 review found that fatty liver may worsen faster during HIV care [13]. Another review linked that risk with too much fat deep in the belly [14]. Doctors needed better choices. They also wanted to know whether newer HIV medicines changed the result.
One trial tested tesamorelin in people with fatty liver [7]. A later trial asked if the shot still worked beside newer HIV medicines [9]. It did: belly and liver readings fell together. An earlier scan study found the same direction of change [6].
These studies answered a narrow care question. They didn't test fatty liver in the public at large. The people studied were receiving HIV treatment.
Liver scans could not show whether scars healed
Scans measure fat, not scar tissue. The trials used scans to track liver fat [6][7][9]. Less fat on a scan doesn't prove that scars healed [7]. A biopsy tests a tiny piece of liver and answers that other question.
In one study, more than a third reached a liver-fat reading below 5% [7]. The study treated that level as normal. It didn't prove that scars healed or slowed. No trial ran long enough to measure liver failure or death [7].
Reviews want biopsy results before calling the liver itself healthier [13]. The shots lowered fat but didn't prove a cure. The fatty liver research findings keep that limit clear [9]. You can ask which kind of test your doctor means.
Tesamorelin lowered liver fat beside newer HIV medicines
One hospital trial measured less liver fat after tesamorelin [6]. A 2024 trial followed people taking newer HIV medicines. Their scans found the same change [9].
A 2019 trial also found less liver fat. The drop was 37% compared with placebo [7]. A placebo is a shot with no medicine. Fat stayed lower while treatment continued.
Tesamorelin still lacks approval for fatty liver disease
A year-long study found 37% less liver fat than with placebo [7]. About 35% of treated people reached a reading below 5%, a level the study treated as normal. Only 4% of the placebo group reached that level.
Researchers are still asking what those scan changes mean for liver health. Large liver-disease trials aren't complete. Tesamorelin hasn't received approval for fatty liver disease.
Tesamorelin may lower liver fat by lowering belly fat
Fatty liver can be serious during HIV care [13][14]. Tesamorelin trials found less fat deep in the belly. That may leave less fat traveling toward the liver [6][8]. Liver scans improved, but the studies didn't prove a cure.